NCT04446416 2023-09-06Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM PatientsNaviFUS CorporationPhase NA Completed6 enrolled
NCT00595322 2017-05-23Bevacizumab in the Radiation Treatment of Recurrent Malignant GliomaMemorial Sloan Kettering Cancer CenterPhase NA Completed25 enrolled
NCT01017250 2014-02-28Radiosurgery and Avastin for Recurrent Malignant GliomasDuke UniversityPhase NA Completed15 enrolled 23 charts